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Abstract: Frontotemporal dementia (FTD) is a clinically and
pathologically heterogeneous neurodegenerative disorder asso-
ciated with atrophy of the frontal and temporal lobes. Most
patients with focal temporal lobe atrophy present with either the
semantic dementia subtype of FTD or the behavioral variant
subtype. For patients with temporal variant FTD, the most
common cause found on post-mortem examination has been a
TDP-43 (transactive response DNA-binding protein 43 kDa)
proteinopathy, but tauopathies have also been described, in-
cluding Pick’s disease and mutations in the microtubule-asso-
ciated protein tau (MAPT) gene. We report the clinical and
imaging features of 2 patients with temporal variant FTD as-
sociated with a rare frontotemporal lobar degeneration pathol-
ogy known as globular glial tauopathy. The pathologic
diagnosis of globular glial tauopathy should be considered in
patients with temporal variant FTD, particularly those who
have atypical semantic dementia or an atypical parkinsonian
syndrome in association with the right temporal variant.
Key Words: tauopathy, frontotemporal dementia, parkinsonism
(Cogn Behav Neurol 2015;28:92–97)
bvFTD=behavioral variant frontotemporal dementia. FTD=
frontotemporal dementia. FTLD=frontotemporal lobar de-
generation. GGT=globular glial tauopathy. 4R=4-repeat.
TDP-43=transactive response DNA-binding protein 43 kDa.
Frontotemporal dementia (FTD) is a common early-onset dementia, usually presenting with behavioral or
language impairment and associated with atrophy of the
frontal and/or temporal lobes (Seelaar et al, 2011). Most
patients with focal temporal lobe atrophy present clin-
ically with either the semantic dementia subtype of FTD
or the behavioral variant (bvFTD) subtype. When tem-
poral atrophy is asymmetric and left side-predominant,
the clinical diagnosis is usually semantic dementia, but
when the atrophy is predominantly right-sided, the initial
symptoms are usually behavioral (Seeley et al, 2005).
In addition to variation in clinical presentation,
FTD is heterogeneous pathologically. In temporal variant
FTD, a TDP-43 (transactive response DNA-binding
protein 43 kDa) proteinopathy has been the most com-
mon cause found at post-mortem examination, but
tauopathies have also been described, including Pick’s
disease and mutations in the microtubule-associated
protein tau gene (MAPT) (Josephs et al, 2009).
The term globular glial tauopathy (GGT) was re-
cently coined (Ahmed et al, 2011, 2013) to describe a
group of neurodegenerative disorders characterized by
globular glial and neuronal tau-immunoreactive cyto-
plasmic inclusions. In all GGT subtypes, significant de-
generation of the white matter is also a characteristic
feature (Ahmed et al, 2011, 2013). At present, GGTs
comprise 3 subgroups, named Types I, II, and III.
Here we report our evaluation of the clinical,
imaging, and pathologic features of 2 patients with tem-
poral variant FTD associated with frontotemporal lobar
degeneration (FTLD)-tau pathology corresponding to
GGT Type I.
CASE REPORTS
Patient 1
A 77-year-old woman attended our clinic with a 3-
year history of change in behavior (Table 1). She had
become apathetic and socially withdrawn, with abnormal
eating behavior (often cramming food into her mouth),
disinhibition (once removing all her clothes in public),
and hypersexuality.
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One year before we saw her, her family noted that her
thinking had become slower and her memory impaired. Six
months before we saw her, she had started walking more
slowly than before, with stiffness and difficulty using her
left arm and leg. Over the few months before we saw her,
she started to fall more often than before, mostly back-
ward. She had no family history of note.
When we evaluated the patient, she had a Mini-
Mental State Examination (Folstein et al, 1975) score of 23/
30, losing points on orientation to place and time, sentence
repetition, copying, and sentence writing. Further psycho-
metric testing revealed marked executive dysfunction, pro-
found slowing of information processing speed, and
impaired recognition memory for faces; however, she had
relatively intact memory for words.
She was hypomimic and hypophonic. She had dif-
ficulty initiating saccades and a slowing of vertical sac-
cadic eye movements, particularly in downgaze. There
was asymmetric bradykinesia and rigidity in the limbs,
worse on the left side, without a tremor. She had
myoclonus and apraxia in the upper limbs, worse on the
left. She had a stooped posture with axial rigidity, and a
slow, shuffling gait.
The clinical diagnosis was bvFTD with an atypical
parkinsonian disorder. Magnetic resonance imaging of
the patient’s brain showed focal right temporal lobe
atrophy, particularly anteriorly (Figure 1). She had a
trial of levodopa, with no improvement. Her condition
deteriorated and she died 6 months later.
Patient 2
A 78-year-old woman attended our clinic with a 3-
year history of word-finding difficulties (Table 1). She had
been noted to be mildly disinhibited and inappropriately
jocular. Her mother had a late-onset dementia, but there
was no other notable family history.
When we evaluated the patient, she had a Mini-
Mental State Examination score of 21/30, losing points
on orientation, recall, sentence writing, and copying.
Further psychometric testing revealed a profound
anomia, dyscalculia, impairment on the vocabulary
subtest of the Wechsler Adult Intelligence Scales–Third
Edition (Wechsler, 1997), executive dysfunction, and im-
paired recognition memory for both faces and words. She
had evidence of limb apraxia, but an otherwise normal
neurologic examination.
A clinical diagnosis of semantic dementia was made,
although it was felt to be atypical because of her dyscalculia
and limb apraxia. Magnetic resonance imaging of her brain
(Figure 1) showed temporal lobe atrophy, particularly an-
teriorly, and worse on the left side than the right. She
also had white matter changes that were thought to be
secondary to associated small-vessel disease.
Over the next year she became almost mute, able to
say only “yes” and “no,” and she laughed in response to
most questions. She continued to decline over the next 2
years, becoming abulic and incontinent of both bladder
and bowel. When we last evaluated her, 3 years after our
initial assessment, she was still able to walk, although her
gait was apraxic. She was not seen again in the clinic. She
died 2 years after our last assessment.
PATHOLOGY
With appropriate consents, the 2 patients’ brains were
donated to the Queen Square Brain Bank for Neuro-
logical Disorders, Department of Molecular Neuroscience,
TABLE 1. Comparison of the Patients’ Demographic, Clinical, Behavioral, Cognitive, and
Imaging Features
Patient 1 Patient 2
Demographics
Sex Female Female
Age at onset (years) 74 75
Age at death (years) 77 83
Clinical features
Main syndrome Behavioral variant
frontotemporal dementia
Atypical semantic dementia
Extrapyramidal features + 
Pyramidal features  
Behavioral features
Disinhibition + +
Apathy + +
Abnormal eating behavior + 
Cognitive features
Executive dysfunction + +
Language impairment  +
Episodic memory
impairment
+ +
Parietal lobe dysfunction  +
Imaging features
Symmetry of atrophy Right>Left Left>Right
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University College London. The protocols used by the
Brain Bank have been approved by a London Multicentre
Ethics Committee, and tissue is stored under a license from
the Human Tissue Authority.
Gross Pathology
Patient 1
We examined Patient 1’s right half brain, which
weighed 609 g (Table 2). We found severe dilatation of the
right lateral ventricle. There was moderate cortical atrophy,
which involved the entire frontal lobe (including the motor
strip and gyri of its medial surface) and the temporal lobe.
The body of the caudate nucleus was mildly reduced in
bulk, and there was severe atrophy of the amygdala and
hippocampus. The substantia nigra was pale.
Patient 2
Patient 2’s left half brain, weighing 506 g, showed
severe frontotemporal atrophy with focally narrow gyri
(Table 2). The cortical atrophy was severe in the
prefrontal region and the temporal lobe, and also in-
volved the fusiform and parahippocampal gyri. The deep
white matter of the anterior frontal lobe and anterior
temporal lobe was severely reduced in bulk and had a
granular surface. There was also a reduction in bulk of
the caudate nucleus, severe atrophy of the amygdala and
hippocampus, and pallor of the substantia nigra and lo-
cus coeruleus.
Microscopic Findings
Microscopic assessment revealed a “primary” 4-re-
peat (4R) tauopathy in both patients, with morphologic
appearances in keeping with GGT Type I.
Patient 1
Our findings in Patient 1 are described in Table 2
and illustrated in Supplemental Digital Content 1 (http://
links.lww.com/CBN/A60) Panels D–G, I, and J.
Patient 1 had marked anterior frontal and temporal
cortical nerve cell loss, accompanied by severe 4R-tau de-
posits in both cerebral cortex and subcortical and deep
white matter. Also among the most severely affected
regions were the temporal pole and medial temporal lobe
structures, including the hippocampus, amygdala, and
parahippocampal and fusiform gyri. Similar pathology was
present in the basal ganglia, including the subthalamic
nucleus and globus pallidus, and in brain stem structures.
The tau-positive neuronal cytoplasmic inclusions,
seen in affected cerebral cortices, basal ganglia, and brain
stem nuclei, were represented either by diffuse cytoplasmic
immunoreactivity, often with appearances of pretangles, or
by coarse globular 4R-tau-positive cytoplasmic deposits
(globular neuronal inclusions), occasionally mimicking the
morphologic appearances of Pick bodies.
There was astrocytic tau pathology in affected gray
matter structures, with the tau-positive astrocytes showing a
granular staining pattern or containing small globular de-
posits (Supplemental Digital Content 1, http://links.lww.com/
CBN/A60, Panel G). These appearances were strikingly dif-
ferent from those seen in tufted astrocytes, which possess
delicate filamentous processes. Importantly, the astrocytic in-
clusions remained unstained on Gallyas silver preparations.
Tau-positive neuropil threads and oligodendroglial
cytoplasmic inclusions with appearances of either typical
globular oligodendroglial inclusions or coiled bodies were
numerous in the subcortical and hemispheric deep white
matter, including the centrum semiovale; the internal, ex-
ternal, and extreme capsules; and the anterior commissure
(Supplemental Digital Content 1, http://links.lww.com/
CBN/A60, Panels D, F, I, and J), as well as the fronto-
pontine and temporopontine tracts in the cerebral peduncle.
The CA1 hippocampal subregion and subiculum
showed severe loss of neurons, accompanied by astrogliosis
(hippocampal sclerosis), with remaining neurons containing
tau-positive neuronal cytoplasmic inclusions. The locus
coeruleus showed mild depletion of neurons, and several
of the remaining neurons contained tau-positive neuronal
cytoplasmic inclusions, including globular neuronal in-
clusions. The tegmentum of the medulla contained neuro-
fibrillary tangles and coarse neuronal tau-positive deposits.
FIGURE 1. Coronal T1 magnetic resonance scans in our patients, performed 3 years after symptom onset. In Patient 1 (upper
panel), there is focal right anteromedial temporal lobe atrophy. In Patient 2 (lower panel), there is anteromedial temporal lobe
atrophy, left more severe than right.
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Patient 2
Our findings in Patient 2 are described in Table 2
and illustrated in Supplemental Digital Content 1 (http://
links.lww.com/CBN/A60) Panels A–C and H.
Patient 2’s frontal and temporal lobes showed se-
vere disruption of the normal cortical architecture, with
spongiosis of cortical neuropil affecting all cortical lami-
nae in the most affected areas. The cortical involvement
was distributed in a pattern that is often seen in cases of
FTLD, in that the posterior part of the superior temporal
gyrus was better preserved, while all of the temporal gyri
were severely affected in the anterior temporal lobe. There
was also marked pallor of the white matter underlying
affected cerebral cortices in the temporal and prefrontal
regions, accompanied by astrogliosis.
Like Patient 1, Patient 2 had 4R-tau-positive neu-
ronal cytoplasmic inclusions, including globular neuronal
inclusions and pretangle-type inclusions, as well as glial
(both oligodendroglial and astrocytic) inclusions (Sup-
plemental Digital Content 1, http://links.lww.com/CBN/
A60, Panels B, C, and H). The oliogodendroglial
inclusions were mostly of the globular type and were
particularly numerous in the white matter areas showing
pallor (Panel B). The tau-positive astrocytic inclusions,
seen in affected gray matter structures, showed either a
globular or a finely punctate staining pattern (Panel H),
and were negative for Gallyas silver staining. Fine
tau-positive neuropil threads and small dots were also
seen in the gray matter structures.
The tau pathology involving the cerebral cortex was
less severe than that in the underlying white matter
(Panel C). The CA1 hippocampal subregion and subic-
ulum showed severe neuronal depletion, accompanied by
astrogliosis (Panel A). Tau-positive neurons were seen in
the granule cells of the dentate fascia, CA1 hippocampal
subregion, subiculum, and parahippocampus.
Involvement of the white matter by globular oligo-
dendroglial inclusions was severe throughout the medial
temporal lobe structures. Neuronal cytoplasmic inclusions
were seen in the striatum, with involvement of the pencil
fibers by tau-positive globular oligodendroglial inclusions.
The subthalamic nucleus showed no significant cell loss,
with minimal loss in the globus pallidus. Tau-positive
neuronal cytoplasmic inclusions were seen in both struc-
tures, and the globus pallidus also had globular oligoden-
droglial inclusions. There was modest neuronal loss in the
substantia nigra, with neuropil threads, neuronal cyto-
plasmic inclusions, and globular oligodendroglial inclusions
seen here as well as the midbrain and pontine tegmentum.
The locus coeruleus showed considerable nerve cell loss.
There was no significant loss of neurons in the in-
ferior olivary nucleus, which contained modest numbers
of tau-positive neuropil threads and occasional pretangle-
type neuronal cytoplasmic inclusions.
In both patients, the cerebellar cortex showed only
very mild loss of Purkinje cells, and the neuronal population
of the dentate nucleus was well preserved. Both patients had
sparse globular oligodendroglial inclusions in the cerebellar
white matter and occasional pretangle-type neuronal cyto-
plasmic inclusions and globular neuronal inclusions in the
dentate nucleus. Patient 1 had occasional ballooned neurons
in prefrontal and limbic areas.
Neither patient had astrocytic plaques or argyro-
philic grains. Patient 1 showed additional amyloid
b-positive pathology in the temporal and parietal cortices
and the entorhinal cortex, corresponding to Thal phase 2.
Patient 2 showed a moderate degree of cerebral amyloid
angiopathy in the frontal region.
Neither patient had evidence of TDP-43 pathology
in any brain area.
DISCUSSION
Both of our patients had clinical and imaging fea-
tures suggestive of asymmetric focal temporal lobe in-
volvement. Furthermore, at post-mortem, both showed
morphologic features of FTLD, with microscopic evi-
dence of GGT Type I. On the basis of the morphologic
findings, including abundant globular oligodendroglial
and astrocytic inclusions, the pathology in our patients
could be differentiated unequivocally from other forms of
FTLD-tau such as Pick’s disease, corticobasal degener-
ation, and progressive supranuclear palsy.
As noted in the introduction, the term GGT was
recently coined by Ahmed et al (2011, 2013) for a group
of 4R-tauopathies, which, among other pathologic
changes, are characterized by globular glial (both oligo-
dendroglial and astrocytic) cytoplasmic tau inclusions. At
present, 3 pathologic subgroups are recognized. The Type
I subgroup is represented by cases that were previously
reported as “sporadic multiple system tauopathy with
dementia” and “white matter tauopathy with globular
glial inclusions” (Ahmed et al, 2011; Bigio et al,
2001; Kovacs et al, 2008), and are characterized by a
frontotemporal predominance of globular oligoden-
droglial inclusions The 2 patients reported here met the
diagnostic criteria for Type I GGT. Type II cases, in
which the motor cortex and corticospinal tract are se-
verely affected, were previously reported as “atypical
progressive supranuclear palsy with corticospinal tract
degeneration” (Josephs et al, 2006). In Type III cases, in
addition to severe frontotemporal lobar involvement, the
motor cortex and corticospinal tract also show severe tau
pathology, including globular oligodendroglial inclusions
(Fu et al, 2010).
In patients with a pathologic diagnosis of GGT, the
clinical diagnoses have been bvFTD, atypical parkinso-
nian disorders (including progressive supranuclear palsy
and corticobasal syndrome), and motor neuron disease
(including the upper motor neuron variant primary lat-
eral sclerosis). A number of patients have had features of
>1 of these syndromes. Our Patient 1 presented initially
with bvFTD, and then developed atypical parkinsonian
features without any clinical evidence of motor neuron
disease. Our Patient 2 had a progressive language dis-
order within the FTD spectrum.
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Focal right temporal lobe atrophy has been described
in a number of patients with FTD, usually presenting with
either bvFTD or semantic dementia (Chan et al, 2009;
Josephs et al, 2009). In 2009, Josephs et al found that these 2
clinical presentations segregated with the underlying path-
ology in that patients diagnosed with bvFTD had underlying
tau pathology (either Pick’s disease or mutations in the tau
gene), while patients with semantic dementia had underlying
TDP-43 pathology, corresponding to FTLD-TDP Type C in
the “harmonized” classification of FTLDs (Mackenzie et al,
2011). The patients with bvFTD (and FTLD-tau) were more
likely to develop parkinsonism and abnormal eating
behavior, but less likely to develop prosopagnosia or top-
ographagnosia, consistent with our Patient 1.
In 2012, Coon et al described a further subtype of
right temporal variant FTD in patients who had asso-
ciated motor neuron disease. However, all of these pa-
tients had FTLD-TDP Type B pathology (Mackenzie
et al, 2011). Focal left temporal lobe atrophy is usually
associated with semantic dementia and underlying TDP-
43 Type C pathology (Rohrer et al, 2010), but there have
been reports of patients with focal left temporal lobe
atrophy having tauopathies such as Pick’s disease, par-
ticularly when the patients have atypical features, eg,
neuropsychological abnormalities suggesting parietal lobe
involvement (Rohrer et al, 2011).
In summary, the pathologic diagnosis of GGT should
be considered in patients with temporal variant FTD, par-
ticularly in those with semantic dementia who have atypical
features and in those with the right temporal variant who
have an atypical parkinsonian syndrome.
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